-
森燃心动 福爱e生之星火燎e系列会
2020-04-29 16284 看过 免费 -
龚学忠：新冠肺炎合并急性肾损伤
2020-04-28 34448 看过 免费 -
第一期：新形势下的肿瘤合理用药管理
话题一：从政策更新谈肿瘤合理用药的管理话题二：解读2019版新型抗肿瘤药物临床应用指导原则话题三：免疫治疗合理用药的挑战和解决之道
2020-04-28 28047 看过 免费 -
【关爱肾脏，合理用药】线上会议
2020-04-28 40568 看过 免费 -
悉听我说 第四期
2020-04-27 28084 看过 免费 -
悉听我说 第三期
狼疮性肾炎规范化诊疗的探讨
2020-04-25 30071 看过 免费 -
悉听我说第二期
2020-04-24 28747 看过 免费 -
第六期 中西医结合疾病管理“心”模式
2020-04-23 53692 看过 免费 -
空中对话系列|第三期
协办单位：中国医学论坛报社
2020-04-23 27079 看过 免费 -
CMT introudctions
China Medical Tribune was founded in 1983. It is a professional medical media co-founded by the former Ministry of Health and Sackler Foundation. It is a public institution under the Center for International Exchange and Cooperation, National Health Commission. CMT adheres to the spirit of dedication, innovation and responsibility. It is committed to conveying the advances and attracting fields of studies in medical science and clinical practice at home and abroad to 2 million Chinese doctors in the principle of evidence-based reporting methods; and it also provides the latest medical information and solutions to clinical problems. CMT listens to different academic voices and delivers objective medical information to Chinese clinical workers. It is currently one of the largest and most influential professional medical newspaper in China. In addition to the newspaper business, it also covers the scope of online media platforms, including its one and only official medical education-based application CMTopDr, the matrix of wechat public accounts and customized platforms for live conference broadcasting, surveys and collection of real-world medical records.
2020-04-23 16035 看过 免费
直播预告
热门资讯
- 肺癌“治愈”新征程，长三角在行动 第七期
- 肺癌“治愈”新征程，长三角在行动 第八期
- 专访母义明教授④：体重管理面临的主要挑战与应对措施
- 新春团圆，派送健康！请收好这份老年人新冠防护宝典
- 专访母义明教授②：GLP-1RA类代表药物利拉鲁肽、司美格鲁肽、替尔泊肽的特点与临床应用
- 专访母义明教授③：未来GLP-1类药物研究的关键方向
- 专访母义明教授①：GLP-1RA发展历程中的重要突破
- 筑牢防线，派送健康！——春节期间呼吸道传染病科学应对与药物储备
- 李丹教授：从临床实践及循证医学证据看——重症ILD如何使用糖皮质激素和抗纤维化药物
- 减重新药解读！新一代偏向型GLP-1到底偏向哪里？机制与疗效有何不同？
